Logo-aim
Arch Iran Med. 2020;23(4): 283. doi: 10.34172/aim.2020.13
PMID: 32271605

Letter to the Editor

Evaluation of the Level of Anxiety among Iranian Multiple Sclerosis Fellowships During the Outbreak of COVID-19

Abdorreza Naser Moghadasi 1 * ORCID

Cited by CrossRef: 14

1- Shaygannejad V, Afshari-Safavi A, Hatef B. Assessment of mental health, knowledge, and attitude of patients with multiple sclerosis and neuromyelitis optica spectrum disorder in response to 2019 novel coronavirus. Neurol Sci. 2021;42(7):2891 [Crossref]
2- Fiest K, Parsons Leigh J, Krewulak K, Plotnikoff K, Kemp L, Ng-Kamstra J, Stelfox H. Experiences and management of physician psychological symptoms during infectious disease outbreaks: a rapid review. BMC Psychiatry. 2021;21(1) [Crossref]
3- Donisi V, Gajofatto A, Mazzi M, Gobbin F, Busch I, Ghellere A, Rimondini M. Insights for Fostering Resilience in Young Adults With Multiple Sclerosis in the Aftermath of the COVID-19 Emergency: An Italian Survey. Front Psychiatry. 2021;11 [Crossref]
4- Pooja S, Anita T, Anshu P, Monica G. Impact of COVID-19 on Laboratory Health Staff in an Indian Tertiary Care Hospital. Arch Pathol Clin Res. 2023;7(1):001 [Crossref]
5- Silva D, Cobucci R, Soares-Rachetti V, Lima S, Andrade F. Prevalência de ansiedade em profissionais da saúde em tempos de COVID-19: revisão sistemática com metanálise. Ciênc saúde coletiva. 2021;26(2):693 [Crossref]
6- Mishra D, Nair A, Gandhi R, Gogate P, Mathur S, Bhushan P, Srivastav T, Singh H, Sinha B, Singh M. The impact of COVID-19 related lockdown on ophthalmology training programs in India – Outcomes of a survey. Indian J Ophthalmol. 2020;68(6):999 [Crossref]
7- Muller A, Hafstad E, Himmels J, Smedslund G, Flottorp S, Stensland S, Stroobants S, Van de Velde S, Vist G. The mental health impact of the covid-19 pandemic on healthcare workers, and interventions to help them: A rapid systematic review. Psychiatry Research. 2020;293:113441 [Crossref]
8- Arora T, Grey I, Östlundh L, Lam K, Omar O, Arnone D. The prevalence of psychological consequences of COVID-19: A systematic review and meta-analysis of observational studies. J Health Psychol. 2022;27(4):805 [Crossref]
9- Sedighi B, Haghdoost A, Jangipour Afshar P, Abna Z, Bahmani S, Jafari S, Memon A. Multiple sclerosis and COVID-19: A retrospective study in Iran. PLoS ONE. 2023;18(3):e0283538 [Crossref]
10- Shreffler J, Huecker M, Petrey J. The Impact of COVID-19 on Healthcare Worker Wellness: A Scoping Review. WestJEM. 2020;21(5) [Crossref]
11- Oladunjoye A, Oladunjoye O. An evolving problem—Mental health symptoms among health care workers during COVID-19 pandemic. Asian Journal of Psychiatry. 2020;54:102257 [Crossref]
12- da Silva M, Rocha R, Buheji M, Jahrami H, Cunha K. A systematic review of the prevalence of anxiety symptoms during coronavirus epidemics. J Health Psychol. 2021;26(1):115 [Crossref]
13- de Boer D, Hoekstra F, Huetink K, Hoekstra T, Krops L, Hettinga F. Physical Activity, Sedentary Behavior and Well-Being of Adults with Physical Disabilities and/or Chronic Diseases during the First Wave of the COVID-19 Pandemic: A Rapid Review. IJERPH. 2021;18(12):6342 [Crossref]
14- Esteve-Ríos A, García-Sanjuán S, Juliá-Sanchis R, Monasor-Ortolá D, Cabañero-Martínez M. Experience of women with multiple sclerosis during the period of compulsory home confinement due to COVID-19 in Spain. Women & Health. 2022;62(3):214 [Crossref]
15- Donisi V, Gajofatto A, Mazzi M, Gobbin F, Busch I, Ghellere A, Klonova A, Rudi D, Vitali F, Schena F, Del Piccolo L, Rimondini M. A Bio-Psycho-Social Co-created Intervention for Young Adults With Multiple Sclerosis (ESPRIMO): Rationale and Study Protocol for a Feasibility Study. Front Psychol. 2021;12 [Crossref]

SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.